TEVA 22 38 (Cephalexin 250 mg)
Pill imprint TEVA 22 38 has been identified as Cephalexin 250 mg.
Cephalexin is used in the treatment of skin or soft tissue infection; bacterial infection; bladder infection; upper respiratory tract infection; bacterial endocarditis prevention (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- TEVA 22 38
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-2238
More about cephalexin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 204 Reviews – Add your own review/rating
- Drug class: first generation cephalosporins
Consumer resources
Other brands: Keflex, Panixine, Biocef
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
